Clinical trials
Acute Kidney Injury trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 10 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Unknown status | 12 |
| Terminated | 4 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 17 |
| Yonsei University | 16 |
| Asan Medical Center | 7 |
| Samsung Medical Center | 6 |
| Seoul National University Bundang Hospital | 3 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Aptabio Therapeutics, Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Azienda Ospedaliera di Padova | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Kidney Injury | 62 |
| Renal Insufficiency, Chronic | 4 |
| End Stage Liver Disease | 2 |
| Endocarditis | 2 |
| Hepatorenal Syndrome | 2 |
| Liver Cirrhosis | 2 |
| Sepsis | 2 |
| Critical Illness | 1 |
| Emergencies | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.